Drug Research
Enhertu From AZ, Daiichi Sankyo Now Has The FDA Approval
With two significant FDA clearances in as many weeks, Enhertu from AstraZeneca and Daiichi Sankyo is blazing.
On August 11th, the medication obtained rapid approval for...
Drug Research
Pfizer Provides Evidence To Back The Clearance Of Prevnar 20
Although Pfizer beat Merck to sell its next-generation pneumococcal vaccination, it lost a more important battle in June when the FDA said its competitor may...
Drug Research
Hanmi Brings Back Liver Drug After Raising Its Efficacy
After leveraging its microemulsion technology to increase the absorption rate and so address a shortcoming of the original formulation, Hanmi Pharmaceutical has reintroduced its liver...
Drug Research
West Makes Minority Investment in Dublin-Based Latch Medical, a Developer of Vaccine and Biologics Delivery Platforms
West Pharmaceutical Services, Inc. , a global leader in innovative solutions for injectable drug administration, announced it has made a strategic investment in Latch Medical,...
Drug Research
Thermo Fisher Announced FDA Approves First NGS-Based Companion Diagnostic to Aid in Selecting Non-Small C
The U.S. FDA has granted premarket approval to Thermo Fisher Scientific's Oncomine Dx Target Test as a companion diagnostic (CDx) to identify patients whose tumors...
Drug Research
Almac Group Announces $65M Expansion of North American Headquarters in Pennsylvania
Almac Group, the global contract development and manufacturing organisation, today announces a $65 million, 100,000 ft2expansion of clinical supply operations at the company’s North American...
Drug Research
WuXi Advanced Therapies Announces Licensing Agreement with Janssen
WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, announced a licensing agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.